Intrinsic Value of S&P & Nasdaq Contact Us

Ocular Therapeutix, Inc. OCUL NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$25.50
+186.2%

Ocular Therapeutix, Inc. (OCUL) has 20 known insider and institutional holders on record. The largest holder is SUMMER ROAD LLC with 8,591,401 shares. Other notable holders include Opaleye Management Inc. and Dugel Pravin.

Over the last 12 months, insiders have made 58 transactions in OCUL stock — 22 buys (valued at $44.14M) and 29 sells (valued at $3.42M). Insider selling has exceeded buying during this period.

OCUL Insider Ownership

Top Holder
SUMMER ROAD LLC
8,591,401 shares
Buys (12 mo)
22
$44.14M value
Sells (12 mo)
29
$3.42M value
12-Month Transaction Activity
Buy 38%
Sell 50%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Summer Road Llc 10 Percent Owner 8,591,401 2024-02-27
100%
2 Opaleye Management Inc. 10 Percent Owner 4,918,500 2020-01-03
57%
3 Dugel Pravin See Remarks 3,013,022 2026-02-25
35%
4 Sawhney Amarpreet Chairman of the Board 990,563 2019-06-10
12%
5 Mattessich Antony C. President and CEO 549,400 2024-02-06
6%
6 Notman Donald Chief Operating Officer 366,356 2026-02-17
4%
7 Nayak Sanjay Chief Strategy Officer 330,653 2026-02-25
4%
8 Heier Jeffrey S. Chief Scientific Officer 323,368 2026-02-25
4%
9 Waheed Nadia Chief Medical Officer 314,907 2026-02-24
4%
10 Kaiser Peter Chief Development Officer 269,108 2026-02-25
3%
11 Lindstrom Richard L Md Director 246,933 2026-02-24
3%
12 Saroj Namrata Chief Business Officer 240,932 2026-01-06
3%
13 Kitchen Patricia Chief Operating Officer 220,000 2021-02-19
3%
14 Meyers Steve Lawrence Chief Commercial Officer 197,650 2026-01-06
2%
15 Goldstein Michael H. President, Ophthalmology & CMO 190,000 2022-02-07
2%
16 Bollag Daniel M Sr. VP Reg. Affairs & Quality 180,000 2019-01-04
2%
17 Strassburger Philip C. General Counsel 167,522 2024-02-06
2%
18 Ozden Rabia Gurses Chief Medical Officer 159,400 2024-02-06
2%
19 Anderman Todd Chief Legal Officer 152,468 2026-01-06
2%
20 Robinson David Wayne Global Cco 136,000 2026-01-26
2%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-02-23 Nayak Sanjay Chief Strategy Officer Informative Sell 1,759 $8.28 $14.56K
2026-02-23 Kaiser Peter Chief Development Officer Informative Sell 2,810 $8.28 $23.27K
2026-02-23 Dugel Pravin See Remarks Informative Sell 20,056 $8.28 $166.06K
2026-02-23 Heier Jeffrey S. Chief Scientific Officer Informative Sell 3,057 $8.28 $25.31K
2026-02-20 Waheed Nadia Chief Medical Officer Informative Sell 3,510 $7.74 $27.17K
2026-02-20 Lindstrom Richard L Md Director Informative Buy 60,229 $7.66 $461.35K
2026-02-12 Waheed Nadia Chief Medical Officer Informative Sell 7,863 $9.04 $71.08K
2026-02-12 Nayak Sanjay Chief Strategy Officer Informative Sell 10,348 $9.04 $93.55K
2026-02-12 Notman Donald Chief Operating Officer Informative Sell 11,446 $9.04 $103.47K
2026-02-12 Dugel Pravin See Remarks Informative Sell 124,882 $9.04 $1.13M
2026-02-04 Notman Donald Chief Operating Officer Informative Sell 6,035 $8.54 $51.54K
2026-02-02 Notman Donald Chief Operating Officer Informative Sell 5,455 $9.14 $49.86K
2026-01-21 Robinson David Wayne Global Cco RSU Award 136,000 - -
2026-01-21 Robinson David Wayne Officer Unknown - - -
2026-01-20 Robins Jason Shand Interim CFO RSU Award 33,000 $11.45 $377.85K
2026-01-20 Robins Jason Shand Interim CFO Unknown 110,600 $8.12 $898.07K
2026-01-02 Meyers Steve Lawrence Chief Commercial Officer RSU Award 197,650 $11.82 $2.34M
2026-01-02 Saroj Namrata Chief Business Officer RSU Award 240,932 $11.82 $2.85M
2026-01-02 Anderman Todd Chief Legal Officer RSU Award 64,900 - -
2026-01-02 Waheed Nadia Chief Medical Officer RSU Award 240,932 $11.82 $2.85M
2026-01-02 Nayak Sanjay Chief Strategy Officer RSU Award 197,650 $11.82 $2.34M
2026-01-02 Kaiser Peter Chief Development Officer RSU Award 240,932 $11.82 $2.85M
2026-01-02 Notman Donald See Remarks RSU Award 240,932 $11.82 $2.85M
2026-01-02 Heier Jeffrey S. Chief Scientific Officer RSU Award 240,932 $11.82 $2.85M
2025-11-24 Nayak Sanjay Chief Strategy Officer Informative Sell 1,878 $12.04 $22.61K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message